Navigation Links
Cancer researchers receive NIH grant to advance brain tumor therapies from lab to clinical trials
Date:4/24/2008

Cancer researchers at Childrens Hospital of Pittsburgh of UPMC and the University of Pittsburgh Cancer Institute (UPCI) will further develop novel treatments for brain tumors through a new, five-year, $6.24 million grant to the University of Pittsburgh School of Medicine.

The grant from the National Institute of Neurological Disorders and Stroke (NINDS) will fund three projects aimed at developing cutting-edge treatment strategies for a type of brain tumor known as gliomas. The projects are led by principal investigator Ian Pollack, MD, chief of the Division of Pediatric Neurosurgery at Childrens Hospital and director of the UPCI Brain Tumor Program. This is the second five-year grant the Brain Tumor Program project has received from the NINDS.

In the laboratory over the last five years, our researchers have developed three unique and promising approaches to treating gliomas, which are the most common form of brain tumors, Dr. Pollack said. Over the next five years, our goal is to take these approaches from the laboratory to clinical trial and begin to have a direct impact on patients diagnosed with brain tumors.

The three projects and their respective investigators are:

  • Molecularly targeted therapies that interrupt the signaling pathways in the brain that drive tumor growth Dr. Pollack, also the Walter Dandy Professor of Neurosurgery at the University of Pittsburgh School of Medicine

  • Immunotherapy using segments of proteins that are overexpressed by brain tumors to vaccinate patients against tumor growth Hideho Okada, MD, PhD, associate professor in the departments of Neurological Surgery and Surgery at the University of Pittsburgh School of Medicine

  • Viral vectors (a modified herpes virus) to kill tumor cells while leaving other cells intact Joseph C. Glorioso III, PhD, chair of the Department of Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine; and Paola Grandi, PhD, an assistant professor in the departments of Neurological Surgery and Microbiology and Molecular Genetics at the University of Pittsburgh School of Medicine

Every year about 19,000 children and adults are diagnosed with primary brain tumors, according to the National Cancer Institute. Malignant gliomas are the most common, accounting for more than half and including astrocytomas, oligodendrogliomas and glioblastoma multiforme.

Current conventional therapies for malignant brain tumors, including surgery, radiation and chemotherapy, are often unsatisfactory for controlling these tumors, and the vast majority recur, Dr. Pollack said. We believe the projects here in Pittsburgh hold promise in improving the treatment of these challenging tumors.


'/>"/>

Contact: Marc Lukasiak
marc.lukasiak@chp.edu
412-692-7919
Children's Hospital of Pittsburgh
Source:Eurekalert

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... ... us, but there are things we can do to improve the odds of staying healthy for ... that there are simple, yet important steps that can be taken to maintain good health and ... her patients include;, , exercise , healthy diet , ...
(Date:4/29/2016)... ... 30, 2016 , ... World Patent Marketing , a ... an automotive invention that improves the storage features of a pick up truck. ... Scott Cooper, CEO and Creative Director of World Patent Marketing. "Over the next ...
(Date:4/29/2016)... , ... April 29, 2016 , ... In an ... and divorcee, shares her enthusiasm for Botox and lip injections, which she underwent in ... youth oriented Coachella Valley Music and Arts Festival. The article explains that Ms. Mirmelli’s ...
(Date:4/29/2016)... ... April 29, 2016 , ... Memorial ... for Graduate Medical Education (ACGME) that it has received accreditation for its residency ... of three residency programs that Memorial is currently pursuing, including Pediatrics and Internal ...
(Date:4/29/2016)... ... 2016 , ... Our bodies are bombarded daily by environmental and lifestyle factors ... stressors is to adopt a more healthful diet, but too many people think that ... Holistic Nutritionist and the creator of the Newport Beach Cleanse and 14-Day Eating Plan, ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... BASEL , Schweiz, April 27, 2016 ... des Sachs CEO Forums in Zürich ... Phase-II-Studie ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung ... (CI) eingesetzt wurde, bekannt. Für die umfassende ... Deutschland und Frankreich angeworben. STR001 wird während ...
(Date:4/27/2016)... , April 27, 2016   ... 42% Growth in Recurring Consumable Sales  Clinical ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) inventor of ... its sales for the first quarter ended March 31, ... the execution of its commercial strategy. First ...
(Date:4/27/2016)... ALBANY, New York , April 27, 2016 /PRNewswire/ ... new market report titled, "Skincare Devices Market - Global ... - 2023." According to the report, the global skincare ... 2014 and is anticipated to expand at a CAGR ... 17,299.4 Mn in 2023. Browse the full Skincare ...
Breaking Medicine Technology: